Acquisition of Dolon by Prescient Healthcare Group

Cells
Deal typePrivate Equity & Transaction Services
IndustryHealthcare
Client namePrescient Healthcare Group
Prescient Healthcare Group has acquired London-based pricing and market access consultancy Dolon. This acquisition strengthens the abilities of Prescient to support global biopharma companies navigating increasingly complex and interconnected clinical, commercial and market access environments.

The acquisition of Dolon represents the next step in Prescient's rapid growth journey, following the acquisition of healthcare consultancy Uptake earlier in 2026. This journey is significantly enhancing the breadth of Prescient's offer to the market.

Dolon will work alongside Prescient's established teams as a dedicated Value, Pricing and Access practice retaining its specialist focus. The partnership will deliver new opportunities for both parties and supports Dolon's next phase of growth within a broader global platform.

BDO supported Prescient Healthcare Group with buy-side financial and tax due diligence services and tax structuring.

The BDO project team included:

Andrew Howson, Sophie Kasiri, Taylor Pearce, Kyle Duncan, Davina Dhaliwal (Financial due diligence)
Brad Payne and Amy Hoare (Tax)